InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Hoberman Kenneth, Director. Insider active across 2 companies, notably TG Therapeutics, INC.. Aggregated, 3 disclosures have been logged. Total volume traded: €101k. The latest transaction was filed on 12 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€100,5826,000 shares@ €16.76370.034% mcap100.0% of flow
Common Stock
SEC:0001104659-22-060913:0·
Ideal exit: 6 Feb 2023 (T+270)
020,000 shares0
COMMON STOCK
SEC:0001104659-21-084258·
020,000 shares0
COMMON STOCK
SEC:0001104659-21-084258:0·
3 of 3 declarations
About Hoberman Kenneth
Kenneth Hoberman is a Board Member at TG THERAPEUTICS, INC. and Nuvectis Pharma, Inc. With expertise in the biopharmaceutical sector, he oversees development and innovation strategies for these companies. His role is crucial in ensuring their success in the market.
